Cel Sci Corp Stock Net Income
| CVM Stock | USD 5.83 0.58 9.05% |
As of the 25th of January, CEL SCI shows the Mean Deviation of 4.76, coefficient of variation of (1,323), and Risk Adjusted Performance of (0.05). CEL SCI Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CEL SCI Corp standard deviation and value at risk to decide if CEL SCI Corp is priced adequately, providing market reflects its regular price of 5.83 per share. Given that CEL SCI has information ratio of (0.09), we suggest you to validate CEL SCI Corp's prevailing market performance to make sure the company can sustain itself in the future.
CEL SCI's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CEL SCI's valuation are provided below:CEL SCI Corp does not right now have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CEL SCI 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CEL SCI's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CEL SCI.
| 10/27/2025 |
| 01/25/2026 |
If you would invest 0.00 in CEL SCI on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding CEL SCI Corp or generate 0.0% return on investment in CEL SCI over 90 days. CEL SCI is related to or competes with INmune Bio, Barinthus Biotherapeutics, Aligos Therapeutics, Kezar Life, OnKure Therapeutics, Tempest Therapeutics, and X4 Pharmaceuticals. CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious ... More
CEL SCI Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CEL SCI's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CEL SCI Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 30.91 | |||
| Value At Risk | (10.73) | |||
| Potential Upside | 10.19 |
CEL SCI Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CEL SCI's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CEL SCI's standard deviation. In reality, there are many statistical measures that can use CEL SCI historical prices to predict the future CEL SCI's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (1.12) | |||
| Treynor Ratio | (1.22) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CEL SCI's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CEL SCI January 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (1.21) | |||
| Mean Deviation | 4.76 | |||
| Coefficient Of Variation | (1,323) | |||
| Standard Deviation | 6.55 | |||
| Variance | 42.91 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (1.12) | |||
| Treynor Ratio | (1.22) | |||
| Maximum Drawdown | 30.91 | |||
| Value At Risk | (10.73) | |||
| Potential Upside | 10.19 | |||
| Skewness | 0.6129 | |||
| Kurtosis | 1.74 |
CEL SCI Corp Backtested Returns
CEL SCI Corp secures Sharpe Ratio (or Efficiency) of -0.0756, which signifies that the company had a -0.0756 % return per unit of return volatility over the last 3 months. CEL SCI Corp exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CEL SCI's Mean Deviation of 4.76, coefficient of variation of (1,323), and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.41, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CEL SCI's returns are expected to increase less than the market. However, during the bear market, the loss of holding CEL SCI is expected to be smaller as well. At this point, CEL SCI Corp has a negative expected return of -0.49%. Please make sure to confirm CEL SCI's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if CEL SCI Corp performance from the past will be repeated in the future.
Auto-correlation | 0.15 |
Insignificant predictability
CEL SCI Corp has insignificant predictability. Overlapping area represents the amount of predictability between CEL SCI time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CEL SCI Corp price movement. The serial correlation of 0.15 indicates that less than 15.0% of current CEL SCI price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.15 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.3 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, CEL SCI Corp reported net income of (25.41 Billion). This is 7545.75% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is significantly higher than that of the company.
CEL Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CEL SCI's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CEL SCI could also be used in its relative valuation, which is a method of valuing CEL SCI by comparing valuation metrics of similar companies.CEL SCI is currently under evaluation in net income category among its peers.
CEL Fundamentals
| Return On Equity | -1.76 | |||
| Return On Asset | -0.56 | |||
| Current Valuation | 47.45 M | |||
| Shares Outstanding | 8.41 M | |||
| Shares Owned By Insiders | 7.71 % | |||
| Shares Owned By Institutions | 10.55 % | |||
| Number Of Shares Shorted | 339.48 K | |||
| Price To Earning | (1.14) X | |||
| Price To Book | 3.07 X | |||
| Price To Sales | 11,797 X | |||
| Gross Profit | (15.89 M) | |||
| EBITDA | (20.88 M) | |||
| Net Income | (25.41 B) | |||
| Cash And Equivalents | 10.95 M | |||
| Cash Per Share | 0.65 X | |||
| Total Debt | 9.38 B | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 7.71 X | |||
| Book Value Per Share | 1.99 X | |||
| Cash Flow From Operations | (17.12 B) | |||
| Short Ratio | 4.62 X | |||
| Earnings Per Share | (6.27) X | |||
| Target Price | 42.5 | |||
| Number Of Employees | 10 | |||
| Beta | 0.55 | |||
| Market Capitalization | 49.02 M | |||
| Total Asset | 28.16 B | |||
| Retained Earnings | (539.42 M) | |||
| Working Capital | 6.47 M | |||
| Current Asset | 5.89 M | |||
| Current Liabilities | 4.01 M | |||
| Net Asset | 28.16 B |
About CEL SCI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CEL SCI Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CEL SCI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CEL SCI Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out CEL SCI Piotroski F Score and CEL SCI Altman Z Score analysis. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.